Keyphrases
Graft-versus-host Disease (GvHD)
100%
T Cells
100%
CD34
100%
Suicide Gene
100%
Thymidine Kinase
100%
Ganciclovir
66%
Herpes Simplex Virus Thymidine Kinase
66%
Transduction Efficiency
33%
Selection Strategy
33%
Suicide Gene Therapy
33%
High Efficiency
16%
Clinical Trials
16%
Extracellular Domain
16%
Transmembrane Domain
16%
Highly Active
16%
Pseudotype
16%
VSV-G
16%
Moloney murine Leukemia Virus
16%
Retrovirus
16%
Kinase Enzymes
16%
Active Site mutant
16%
Multiple Exposures
16%
Human PBMCs
16%
Primary T Cells
16%
Therapy System
16%
IC50
16%
Anti-CD28
16%
Anti-CD3/CD28
16%
Disease Control
16%
Protocol Optimization
16%
Therapy Method
16%
Efficiency Transfer
16%
Magnetic Beads
16%
Biochemistry, Genetics and Molecular Biology
T Cell
100%
Thymidine Kinase
100%
CD34
100%
Suicide Gene
100%
Herpes Simplex Virus
66%
Gene Therapy
33%
Enzyme
16%
Clinical Trial
16%
T Cell Receptor
16%
Transmembrane Domain
16%
IC50
16%
Moloney Murine Leukemia Virus
16%
Vesiculovirus
16%
CD28
16%
Retrovirus
16%
Immobilized Antibody
16%
Immunology and Microbiology
T Cell
100%
Graft-Versus-Host Disease
100%
CD34
100%
Suicide Gene
100%
Herpes Simplex Virus
66%
T Cell Receptor
16%
CD28
16%
Vesiculovirus
16%
Retrovirus
16%
Moloney Murine Leukemia Virus
16%
IC50
16%
Immobilized Antibody
16%
CD3 Antigen
16%
Neuroscience
T Cell
100%
CD34
100%
Thymidine Kinase
100%
Suicide Gene
100%
Herpes Simplex Virus
66%
Ganciclovir
66%
CD28
16%
CD3 Antigen
16%
Immobilized Antibody
16%